Amitiza: payments to doctors
Payments that named Amitiza as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $234K
- Providers
- 7,035
- Transactions
- 15,816
- Average per transaction
- $15
The per-transaction average — $15 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,035 providers the average total is $33, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $225,129 | 96.1% |
| Perrigo Company PLC | $7,800 | 3.3% |
| Mallinckrodt Enterprises LLC | $1,000 | 0.4% |
| Mallinckrodt Hospital Products Inc. | $346 | 0.1% |